CYAND - CYANOTECH CORP
0.29
0 0%
Share volume: 1,999
Last Updated: 03-26-2026
Pharmaceutical Products/Medicinal Chemicals:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$0.29
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 12-31-2024 | 06-30-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q3 2024 | Q1 2025 | Q1 2026 | Q2 2025 | |
| Report Date | 06-20-2025 | 02-11-2025 | 08-06-2025 | 08-06-2025 | 11-10-2025 | |
| Total revenue | 5.156 M | 6.172 M | 5.820 M | 5.820 M | 6.976 M | |
| Cost of revenue | 4.345 M | 3.993 M | 4.047 M | 4.047 M | 4.583 M | |
| Gross profit | 811.000 K | 2.179 M | 1.773 M | 1.773 M | 2.393 M | |
| 168.68% | -18.63% | 0.00% | 34.97% | |||
| Operating expenses | 1.281 M | 1.139 M | 1.374 M | 1.374 M | 1.074 M | |
| Selling general and admin | 940.000 K | 1.012 M | 1.300 M | 1.300 M | 996.000 K | |
| Research and development | 341.000 K | 127.000 K | 74.000 K | 74.000 K | 78.000 K | |
| Total expenses | 3.337 M | 2.229 M | 2.526 M | 2.526 M | 2.203 M | |
| -33.20% | 13.32% | 0.00% | -12.79% | |||
| Operating income | -2.526 M | -50.000 K | -753.000 K | -753.000 K | 190.000 K | |
| Ebit | -2.526 M | -50.000 K | -753.000 K | -753.000 K | 190.000 K | |
| Pretax income | -2.684 M | -224.000 K | -926.000 K | -926.000 K | 1.000 K | |
| -91.65% | 313.39% | 0.00% | -100.11% | |||
| Income tax | 7.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.691 M | -224.000 K | -926.000 K | -926.000 K | 1.000 K | |
| 91.68% | -313.39% | 0.00% | 100.11% |